Reviewing the role of healthy volunteer studies in drug development

JJ Karakunnel, N Bui, L Palaniappan… - Journal of translational …, 2018 - Springer
Background With the exception of genotoxic oncology drugs, first-in-human, Phase 1 clinical
studies of investigational drugs have traditionally been conducted in healthy volunteers …

Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy

E Jamrozik, MJ Selgelid - Journal of Medical Ethics, 2020 - jme.bmj.com
Human infection challenge studies (HCS) involve intentionally infecting research
participants with pathogens (or other micro-organisms). There have been recent calls for …

[КНИГА][B] Human challenge studies in endemic settings: ethical and regulatory issues

E Jamrozik, MJ Selgelid - 2021 - library.oapen.org
This open access book provides an extensive review of ethical and regulatory issues related
to human infection challenge studies, with a particular focus on the expansion of this type of …

Consider drug efficacy before first-in-human trials

J Kimmelman, C Federico - Nature, 2017 - nature.com
Consider drug efficacy before first-in-human trials | Nature Skip to main content Thank you for
visiting nature.com. You are using a browser version with limited support for CSS. To obtain the …

Promoting ethical payment in human infection challenge studies

HF Lynch, TC Darton, J Levy, F McCormick… - The American Journal …, 2021 - Taylor & Francis
To prepare for potential human infection challenge studies (HICS) involving SARS-CoV-2,
we convened a multidisciplinary working group to address ethical questions regarding …

Healthy volunteers' perceptions of the benefits of their participation in phase I clinical trials

JA Fisher, L McManus, MM Wood… - Journal of Empirical …, 2018 - journals.sagepub.com
Other than the financial motivations for enrolling in Phase I trials, research on how healthy
volunteers perceive the benefits of their trial participation is scant. Using qualitative …

“Paid to endure”: Paid research participation, passivity, and the goods of work

E Malmqvist - The American Journal of Bioethics, 2019 - Taylor & Francis
A growing literature documents the existence of individuals who make a living by
participating in phase I clinical trials for money. Several scholars have noted that the …

Current nonclinical testing paradigms in support of safe clinical trials: An IQ Consortium DruSafe perspective

LD Butler, P Guzzie-Peck, J Hartke… - Regulatory Toxicology …, 2017 - Elsevier
The transition from nonclinical to First-in-Human (FIH) testing is one of the most challenging
steps in drug development. In response to serious outcomes in a recent Phase 1 trial …

The impact of the global COVID‐19 pandemic on the conduct of clinical trials: Return to normalcy by considering the practical impact of a structured ethical analysis

MFJM Vissers, AF Cohen… - British Journal of …, 2021 - Wiley Online Library
During the outbreak of the COVID‐19 pandemic many clinical trials were abruptly halted.
Measures to contain the pandemic are currently taking effect and societies in general and …

Ethical criteria for improved human subject protections in phase I healthy volunteer trials

RL Walker, D MacKay, M Waltz… - Ethics & human …, 2022 - Wiley Online Library
Phase I healthy volunteer trials test the safety and tolerability of investigational
pharmaceuticals. In them, participants are exposed to study‐drug risks without the possibility …